CMS Comments Close on a Rule That Retires the Small Biotech Exemption and Shuts the Hyaluronidase Route

CMS Comments Close on a Rule That Retires the Small Biotech Exemption and Shuts the Hyaluronidase Route

QuickAccess read/Oncology/Antibody CMS Comments Close on a Rule That Retires the Small Biotech Exemption and Shuts the Hyaluronidase Route Athithi Verma· 19 August 2026· 2 min read· Synopulse The 60-day comment period on CMS-4215-P closed at 5pm on 17 August 2026. The proposed rule, published in the Federal Register on 16 June 2026, would codify … Read more